Show your support for the Cruelty-Free Cosmetics Act

The time has come to end animal testing for cosmetics. Animals should not suffer in toxicity tests for the next shade of lipstick or shampoo scent.

The Cruelty-Free Cosmetics Act, SB 1249, will be considered in the California Senate Judiciary committee April 24th. The bill would prohibit the sale of animal-tested cosmetics in the state and is sponsored by Physicians Committee and California group Social Compassion in Legislation (SCIL). Support letters are required by Tuesday, April 17, to the committee chair, Senator Hannah-Beth Jackson.

SB 1249 would make it unlawful for any cosmetic manufacturer to import or sell any cosmetic, including personal hygiene products such as deodorant, shampoo, or conditioner, in California if the final product or any component of the product was tested on animals after Jan. 1, 2020. Because California’s market is so large, this ban could have a big impact on all cosmetics and cosmetics ingredients for sale in the United States.

Nonanimal approaches—including engineered 3-D human skin tissues and other types of cells and sophisticated computer models—are cheaper, faster, and can better predict human reactions. In addition, companies can utilize the hundreds of thousands of ingredients for which safety data is already available.

If the law passes, California would join the European Union, Switzerland, India, Israel, Guatemala, and other countries that have banned or restricted animal testing on cosmetics.

Please send in your letters by the end of the day on Tuesday, April 17. Thank you!


I support SB 1249, the Cruelty-Free Cosmetics Act!

Dear [Decision Maker],

[Your Name]
[Your Address]
[City, State ZIP]


*Required fields

If you take action and have not already registered, you will receive periodic updates and communications.

This site does not provide medical or legal advice. This Web site is for informational purposes only.
Full Disclaimer | Privacy Policy

Physicians Committee for Responsible Medicine
5100 Wisconsin Ave., N.W., Ste.400, Washington DC, 20016
Phone: 202-686-2210 Email: